These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22213244)

  • 1. Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice.
    Volarevic V; Milovanovic M; Ljujic B; Pejnovic N; Arsenijevic N; Nilsson U; Leffler H; Lukic ML
    Hepatology; 2012 Jun; 55(6):1954-64. PubMed ID: 22213244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective role of IL-33/ST2 axis in Con A-induced hepatitis.
    Volarevic V; Mitrovic M; Milovanovic M; Zelen I; Nikolic I; Mitrovic S; Pejnovic N; Arsenijevic N; Lukic ML
    J Hepatol; 2012 Jan; 56(1):26-33. PubMed ID: 21703183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gal-3 regulates the capacity of dendritic cells to promote NKT-cell-induced liver injury.
    Volarevic V; Markovic BS; Bojic S; Stojanovic M; Nilsson U; Leffler H; Besra GS; Arsenijevic N; Paunovic V; Trajkovic V; Lukic ML
    Eur J Immunol; 2015 Feb; 45(2):531-43. PubMed ID: 25359399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice.
    Santucci L; Fiorucci S; Cammilleri F; Servillo G; Federici B; Morelli A
    Hepatology; 2000 Feb; 31(2):399-406. PubMed ID: 10655263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablation of interaction between IL-33 and ST2+ regulatory T cells increases immune cell-mediated hepatitis and activated NK cell liver infiltration.
    Noel G; Arshad MI; Filliol A; Genet V; Rauch M; Lucas-Clerc C; Lehuen A; Girard JP; Piquet-Pellorce C; Samson M
    Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G313-23. PubMed ID: 27340126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin aggravates immune-mediated liver injury in mice.
    Volarevic V; Misirkic M; Vucicevic L; Paunovic V; Simovic Markovic B; Stojanovic M; Milovanovic M; Jakovljevic V; Micic D; Arsenijevic N; Trajkovic V; Lukic ML
    Arch Toxicol; 2015 Mar; 89(3):437-50. PubMed ID: 24770553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD36 deficiency attenuates immune-mediated hepatitis in mice by modulating the proapoptotic effects of CXC chemokine ligand 10.
    Xu C; Zhang C; Ji J; Wang C; Yang J; Geng B; Zhao T; Zhou H; Mu X; Pan J; Hu S; Lv Y; Chen X; Wen H; You Q
    Hepatology; 2018 May; 67(5):1943-1955. PubMed ID: 29220536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism.
    Li B; Sun R; Wei H; Gao B; Tian Z
    Hepatology; 2006 Jun; 43(6):1211-9. PubMed ID: 16729307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor 5 signaling restrains T-cell/natural killer T-cell activation and protects against concanavalin A-induced hepatic injury.
    Wang L; Zhang W; Ge CH; Yin RH; Xiao Y; Zhan YQ; Yu M; Li CY; Ge ZQ; Yang XM
    Hepatology; 2017 Jun; 65(6):2059-2073. PubMed ID: 28273362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protectin D1 reduces concanavalin A-induced liver injury by inhibiting NF-κB-mediated CX3CL1/CX3CR1 axis and NLR family, pyrin domain containing 3 inflammasome activation.
    Ren J; Meng S; Yan B; Yu J; Liu J
    Mol Med Rep; 2016 Apr; 13(4):3627-38. PubMed ID: 26955849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of concanavalin A-induced hepatic injury of mice by bacterial lipopolysaccharide via the induction of IL-6 and the subsequent reduction of IL-4: the cytokine milieu of concanavalin A hepatitis.
    Nishikage T; Seki S; Toyabe S; Abo T; Kagata Y; Iwai T; Hiraide H
    J Hepatol; 1999 Jul; 31(1):18-26. PubMed ID: 10424279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.
    Ju Y; Shang X; Liu Z; Zhang J; Li Y; Shen Y; Liu Y; Liu C; Liu B; Xu L; Wang Y; Zhang B; Zou J
    Mol Immunol; 2014 Mar; 58(1):85-91. PubMed ID: 24333756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs.
    Volarevic V; Markovic BS; Jankovic MG; Djokovic B; Jovicic N; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N; Lukic ML
    Theranostics; 2019; 9(20):5976-6001. PubMed ID: 31534532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superoxide produced by Kupffer cells is an essential effector in concanavalin A-induced hepatitis in mice.
    Nakashima H; Kinoshita M; Nakashima M; Habu Y; Shono S; Uchida T; Shinomiya N; Seki S
    Hepatology; 2008 Dec; 48(6):1979-88. PubMed ID: 18942689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin deficiency, not obesity, protects mice from Con A-induced hepatitis.
    Siegmund B; Lear-Kaul KC; Faggioni R; Fantuzzi G
    Eur J Immunol; 2002 Feb; 32(2):552-60. PubMed ID: 11828372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines.
    Fiorucci S; Santucci L; Antonelli E; Distrutti E; Del Sero G; Morelli O; Romani L; Federici B; Del Soldato P; Morelli A
    Gastroenterology; 2000 Feb; 118(2):404-21. PubMed ID: 10648469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of Roquin aggravates T cell mediated hepatitis in transgenic mice using T cell specific promoter.
    Ji YR; Kim HJ; Yu DH; Bae KB; Park SJ; Park SJ; Jang WY; Kang MC; Jeong J; Sung YH; Choi M; Park T; Park T; Yun JW; Lee HS; Lee S; Kim MO; Ryoo ZY
    Biochem Biophys Res Commun; 2014 Sep; 452(3):822-7. PubMed ID: 25201726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of Galectin-3 in autoimmunity and tumor progression.
    Radosavljevic G; Volarevic V; Jovanovic I; Milovanovic M; Pejnovic N; Arsenijevic N; Hsu DK; Lukic ML
    Immunol Res; 2012 Apr; 52(1-2):100-10. PubMed ID: 22418727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High susceptibility to liver injury in IL-27 p28 conditional knockout mice involves intrinsic interferon-γ dysregulation of CD4+ T cells.
    Zhang S; Liang R; Luo W; Liu C; Wu X; Gao Y; Hao J; Cao G; Chen X; Wei J; Xia S; Li Z; Wen T; Wu Y; Zhou X; Wang P; Zhao L; Wu Z; Xiong S; Gao X; Gao X; Chen Y; Ge Q; Tian Z; Yin Z
    Hepatology; 2013 Apr; 57(4):1620-31. PubMed ID: 23175475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-25 prevents and cures fulminant hepatitis in mice through a myeloid-derived suppressor cell-dependent mechanism.
    Sarra M; Cupi ML; Bernardini R; Ronchetti G; Monteleone I; Ranalli M; Franzè E; Rizzo A; Colantoni A; Caprioli F; Maggioni M; Gambacurta A; Mattei M; Macdonald TT; Pallone F; Monteleone G
    Hepatology; 2013 Oct; 58(4):1436-50. PubMed ID: 23564603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.